FDA Accepts Amgen's New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. HUBS
3. SPY
4. AAPL
5. RARE
6. INTU
7. AUTO
8. AZN
9. BETR
10. TRMD

Go back to FDA Accepts Amgen's New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide
Amgen Inc (NASDAQ: AMGN) Delayed: 379.78 --0 (-0%)
Previous Close $379.78    52 Week High $176.85 
Open $379.78    52 Week Low $133.64 
Day High $379.78    P/E 57.20 
Day Low $379.78    EPS $6.64 
Volume 4,080